Clinical Trials

Penn Transplant Institute physicians and surgeons are at the forefront of their field in transplantation technology and drug therapy research. Our strides in the laboratory make it possible for us to provide cutting-edge medical care for our patients. Clinical trials are currently available for heart, kidney, liver, lung and islet transplant patients:

Frequently Asked Questions about Clinical Trials

  • What is a clinical trial?

    A clinical trial is a medical research study conducted to evaluate a new treatment option. This treatment could take the form of a new drug or therapy.

    The goal of a clinical trial is to test a new treatment with a small group – and then use the information obtained to develop medical treatment options that help many people. Before a new treatment is attempted with patients, it is carefully studied in order to determine safe parameters for the study and to increase the likelihood of success in the actual trial.

  • What can I expect from a clinical trial?

    Clinical trial patients join a study for a variety of reasons – they may wish to cure themselves, prolong their lives or help others with a similar condition. Clinical trial patients are among the first to try a new medicine or therapy in the hope that their success will lead to a breakthrough. A Penn research coordinator carefully explains potential risks and benefits before any commitment is made.

  • How can I enroll in a clinical trial?

    Speak to your transplant coordinator at your next visit to the Penn Transplant Institute. He or she will be happy to refer you to the research coordinator connected with individual studies.

 

Need an appointment? Request one online 24 hours/day, 7 days/week or call 800-789-PENN (7366) to speak to a referral counselor.

Request an Appointment

Make a Gift to the Clyde F. Barker Transplant House

Clinical Trials